A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008208/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of an intravenous treatment
regimen of two doses of anifrolumab versus placebo in adult subjects with moderately to
severely active, autoantibody-positive systemic lupus erythematosus (SLE).
提供机构：
Vivli
创建时间：
2022-07-06
